Cargando…
Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
This study focusses on the fabrication of nano-carriers for delivery of ciprofloxacin through the nanoprecipitation process. This was done to examine the release of drug at the pH of stomach to find out the antibacterial action of ciprofloxacin loaded nanoparticles (NPs). Prepared NPs were character...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893093/ https://www.ncbi.nlm.nih.gov/pubmed/36743194 http://dx.doi.org/10.1177/15593258231152117 |
_version_ | 1784881453399539712 |
---|---|
author | Bukhari, Attaullah Fatima, Zuha Atta, Madiha Nazir, Arif Alshawwa, Samar Z. Alotaibi, Hadil F. Iqbal, Munawar |
author_facet | Bukhari, Attaullah Fatima, Zuha Atta, Madiha Nazir, Arif Alshawwa, Samar Z. Alotaibi, Hadil F. Iqbal, Munawar |
author_sort | Bukhari, Attaullah |
collection | PubMed |
description | This study focusses on the fabrication of nano-carriers for delivery of ciprofloxacin through the nanoprecipitation process. This was done to examine the release of drug at the pH of stomach to find out the antibacterial action of ciprofloxacin loaded nanoparticles (NPs). Prepared NPs were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), and particle size analyzer (PSA) techniques. Drug yield, loading, and sustained release was studied as function of time (up to 8 h). Antibacterial activity of ciprofloxacin loaded NPs were also determined against different gram-positive and gram-negative bacteria. Results revealed that nanoprecipitation is a suitable method for encapsulation of ciprofloxacin in poly(lactic-co-glycolic acid) PLGA NPs. The drug yield and drug loading were found to be 60%. The size range of NPs observed by PSA was in the range of 5.03–6.60 nm. It can be concluded that nanoformulation of ciprofloxacin loaded PLGA NPs can be used in stomach for longer period of time to enhance the bioavailability of the drug. |
format | Online Article Text |
id | pubmed-9893093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-98930932023-02-03 Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties Bukhari, Attaullah Fatima, Zuha Atta, Madiha Nazir, Arif Alshawwa, Samar Z. Alotaibi, Hadil F. Iqbal, Munawar Dose Response Original Article This study focusses on the fabrication of nano-carriers for delivery of ciprofloxacin through the nanoprecipitation process. This was done to examine the release of drug at the pH of stomach to find out the antibacterial action of ciprofloxacin loaded nanoparticles (NPs). Prepared NPs were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), and particle size analyzer (PSA) techniques. Drug yield, loading, and sustained release was studied as function of time (up to 8 h). Antibacterial activity of ciprofloxacin loaded NPs were also determined against different gram-positive and gram-negative bacteria. Results revealed that nanoprecipitation is a suitable method for encapsulation of ciprofloxacin in poly(lactic-co-glycolic acid) PLGA NPs. The drug yield and drug loading were found to be 60%. The size range of NPs observed by PSA was in the range of 5.03–6.60 nm. It can be concluded that nanoformulation of ciprofloxacin loaded PLGA NPs can be used in stomach for longer period of time to enhance the bioavailability of the drug. SAGE Publications 2023-01-30 /pmc/articles/PMC9893093/ /pubmed/36743194 http://dx.doi.org/10.1177/15593258231152117 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Bukhari, Attaullah Fatima, Zuha Atta, Madiha Nazir, Arif Alshawwa, Samar Z. Alotaibi, Hadil F. Iqbal, Munawar Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties |
title | Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties |
title_full | Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties |
title_fullStr | Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties |
title_full_unstemmed | Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties |
title_short | Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties |
title_sort | poly lactic-co-glycolic acid nano-carriers for encapsulation and controlled release of hydrophobic drug to enhance the bioavailability and antimicrobial properties |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893093/ https://www.ncbi.nlm.nih.gov/pubmed/36743194 http://dx.doi.org/10.1177/15593258231152117 |
work_keys_str_mv | AT bukhariattaullah polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties AT fatimazuha polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties AT attamadiha polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties AT nazirarif polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties AT alshawwasamarz polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties AT alotaibihadilf polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties AT iqbalmunawar polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties |